Biodelivery Sciences Int’l, Inc. v. Aquestive Therapeutics, Appeal Nos. 2019-1643, -1644, -1645 (Fed. Cir. August 29, 2019)
On motion, the Federal Circuit dismissed the second appeals in three IPRs pertaining to oral films used for the delivery of active components. The PTAB initially instituted the three IPRs, but not on all the grounds contained in the petitions. In total, there were seventeen grounds in the petitions, and the PTAB instituted on only three.